Cargando…
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987113/ https://www.ncbi.nlm.nih.gov/pubmed/33759006 http://dx.doi.org/10.1186/s40635-021-00376-w |
| _version_ | 1783668558957379584 |
|---|---|
| author | Honore, Patrick M. Redant, Sebastien De Bels, David |
| author_facet | Honore, Patrick M. Redant, Sebastien De Bels, David |
| author_sort | Honore, Patrick M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7987113 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79871132021-03-24 Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? Honore, Patrick M. Redant, Sebastien De Bels, David Intensive Care Med Exp Editorial Springer International Publishing 2021-03-12 /pmc/articles/PMC7987113/ /pubmed/33759006 http://dx.doi.org/10.1186/s40635-021-00376-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Editorial Honore, Patrick M. Redant, Sebastien De Bels, David Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? |
| title | Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? |
| title_full | Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? |
| title_fullStr | Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? |
| title_full_unstemmed | Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? |
| title_short | Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? |
| title_sort | is an eaa > 0.6 in severe covid-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987113/ https://www.ncbi.nlm.nih.gov/pubmed/33759006 http://dx.doi.org/10.1186/s40635-021-00376-w |
| work_keys_str_mv | AT honorepatrickm isaneaa06inseverecovid19patientssynonymouswithatoxicandproinflammatoryendotoxinprofileandshouldwetreatit AT redantsebastien isaneaa06inseverecovid19patientssynonymouswithatoxicandproinflammatoryendotoxinprofileandshouldwetreatit AT debelsdavid isaneaa06inseverecovid19patientssynonymouswithatoxicandproinflammatoryendotoxinprofileandshouldwetreatit |